58.42
-1.87
(-3.10%)
As of 1:07:15 PM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ACKERMANN CHRISTINA M Director | Purchase | Nov 6, 2024 | 41,880 |
EBSWORTH DAVID R Director | Stock Gift | Feb 26, 2025 | 1,336,000 |
EDWARDS MARTIN Director | Purchase | Nov 20, 2023 | 144,800 |
FISHER ANDREW General Counsel | Stock Award(Grant) | Oct 30, 2024 | 300,000 |
GUPTA RISHI Director | Sale | May 15, 2023 | -- |
HAHN MARK W Chief Financial Officer | Sale | Dec 6, 2024 | 13,293,700 |
ORBIMED ADVISORS, L.L.C. Unknown | Sale | May 15, 2023 | -- |
POLL CLAIRE LOUISE General Counsel | Stock Gift | Feb 1, 2024 | 2,800,410 |
RICKARD KATHLEEN A Officer | Sale | Mar 12, 2025 | 2,608,980 |
ZACCARDELLI DAVID S Chief Executive Officer | Stock Award(Grant) | Jan 31, 2025 | 14,238,000 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
13.52
-12.89%
CYTK Cytokinetics, Incorporated
41.30
+2.61%
MDGL Madrigal Pharmaceuticals, Inc.
328.37
-1.86%
AXSM Axsome Therapeutics, Inc.
108.61
-1.04%
SRRK Scholar Rock Holding Corporation
31.54
-3.07%
BBIO BridgeBio Pharma, Inc.
34.74
+0.35%
SWTX SpringWorks Therapeutics, Inc.
43.65
-6.17%
INSM Insmed Incorporated
73.70
+0.35%
TGTX TG Therapeutics, Inc.
39.46
-0.90%
RNA Avidity Biosciences, Inc.
28.57
-4.03%